Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system from destroying transplanted cells — without using immunosuppressive drugs. Backed by $1 million in funding, the team hopes to create a ready-to-use treatment that could work even for people who have had diabetes for years. The approach could transform how the disease is treated.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Harvard scientists link gut bacteria to depression through hidden inflammation trigger
- Scientists discover why bread can cause weight gain without extra calories
- The dirtiest thing in public bathrooms isn’t the toilet seat
- Men and women with obesity face very different hidden health risks
- Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology
- Scientists discover spice synergy that boosts anti-inflammation 100x
- Scientists discover why flu and COVID hit older adults so hard
- This common vaccine cuts heart risk nearly in half in new study
- The surprising cancer link between cats and humans
- He survived 48 hours without lungs and lived
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
